
What underlies antigen loss after CD19 or CD22 targeted CAR-T? @DomiziPablo and team masterfully demonstrates the important role of IKAROS in antigen loss resistance in our new paper out in @NatureComms rdcu.be/eiViL
English
KLDavisLab
2 posts

@kldavislab
Kara Davis Lab at Stanford University. Using multi-parameter single cell proteomics to study pediatric relapsed leukemias and some solid tumors.
